Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04767
Species: Homo sapiens
Position : chr6:142706180-142706230
Year: 2019
Title: Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: urinary bladder carcinoma
PMID:  30755618
MONDO: MONDO:0004986
Tissue: urinary bladder
Tissue Ontology ID: UBERON:0001255
Cell Source: 5637
CVCL ID: CVCL_0126
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Functional perturbation assay
High Throughput Method: RNA-seq; whole-genome sequencing
Low Throughput Method: RT-RT-qPCR, Western blot
About Target Gene
Target gene : ADGRG6
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_04768 chr6:142706180-142706230 urinary bladder malignant cell urinary bladder carcinoma
E_04781 chr6:142706180-142706230 umbilical vein umbilical vein endothelial cell NA
E_04782 chr6:142706180-142706230 brain neuroblastoma cell NA
Expression of Target Genes for the Enhancer